Brookstone Pharmaceuticals is recalling all lots of Concentrated Acetaminophen Drops in fear of patients overdosing on the drug.
An overdose of Acetaminophen can lead to liver toxicity, kidney damage and blood disorders. The FDA is investigating medication error reports that have lead to deaths and is considering that the concentrated acetaminophen should be removed from the market to lessen consumer confusion. The concentrated Acetaminophen drops contain 80 mg/0.8mL and regular strength Acetaminophen elixir contains 160mg/5mL.
The container that the concentrated drops come in is similar in size to regular strength preparations and the absence of an integrated dosage delivery system is leading to dosage errors and inadvertent overdosing. In efforts to mitigate confusion Brookstone has recalled all lots of its Concentrated Acetaminophen Drops and is requesting that any stores who have the product on its shelf to remove it immediately and return it to Brookstone for a full refund.
If you believe that you or a loved one has been the victim of an inadvertent Acetaminophen overdose contact our experienced Pharmaceutical Litigation Attorneys today.
